Journal article
No Evidence of Moderated Impulsivity Following Administration of the IMPase Inhibitor Ebselen in Healthy Adults
- Abstract:
- Objective: Impulsivity is a transdiagnostic risk factor for numerous health morbidities and is strongly associated with early relapse and poor treatment outcomes in addictions and mood‐disorders. Lithium carbonate can be helpful in moderating the impulsive behaviors associated with mania, possibly mediated by reduced myo‐inositol activity following inhibition of the enzyme inositol monophosphatase (IMPase). We tested the hypothesis that impulsivity—as motor disinhibition, decisions without adequate information, and stronger preferences for small immediate rewards over larger later rewards—can be moderated by the IMPase inhibitor ebselen in healthy adult volunteers. Methods: One hundred and thirty healthy adults completed a between‐subjects, double‐blind, placebo‐controlled protocol. Over 2 days, participants received a previously validated dose of 1800 mg of ebselen or placebo before completing tests of impulsivity and decision‐making. Results: There were no substantive changes in any measure of impulsivity following treatment with ebselen compared with placebo. Neither was there any convincing evidence of stronger treatment effects in high‐trait impulsive participants compared with low‐trait participants. Conclusion: These results fail to replicate findings that ebselen administration moderates validated measures of impulsivity in healthy adults, at least at doses shown to reduce myo‐inositol within the medial prefrontal cortex and produce changes in emotional processing and reward‐based learning.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1006.1KB, Terms of use)
-
- Publisher copy:
- 10.1002/hup.70040
Authors
+ Medical Research Council
More from this funder
- Funder identifier:
- https://ror.org/03x94j517
- Grant:
- MR/L013150/1
- Publisher:
- Wiley
- Journal:
- Human Psychopharmacology: Clinical & Experimental More from this journal
- Volume:
- 41
- Issue:
- 3
- Article number:
- e70040
- Publication date:
- 2026-04-21
- Acceptance date:
- 2026-03-25
- DOI:
- EISSN:
-
1099-1077
- ISSN:
-
0885-6222
- Language:
-
English
- Keywords:
- Pubs id:
-
2411701
- Local pid:
-
pubs:2411701
- Source identifiers:
-
3973798
- Deposit date:
-
2026-04-22
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record